Clinical Research Directory
Browse clinical research sites, groups, and studies.
Post-market Clinical Follow-up Study of NEMOST V2
Sponsor: EUROS
Summary
The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children. As part of post-market surveillance, EUROS is conducting a retrospective and prospective study to collect clinical and radiological data on the NEMOST growth domino. Retrospective and prospective multicenter post-market surveillance clinical study. This study is interventional, non-randomized, and uncontrolled. The primary objective of this clinical study is to monitor complications related to the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children. The secondary objective of this clinical study is to monitor the performance of the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children. The study will include 140 patients.
Official title: Post-market Clinical Follow-up Study of NEMOST V2 Growing Domino
Key Details
Gender
All
Age Range
5 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
140
Start Date
2025-12-19
Completion Date
2033-12-19
Last Updated
2026-02-11
Healthy Volunteers
No
Interventions
NEMOST V2 growing domino
The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children.
Locations (5)
Hopital Lenval Nice
Nice, Provence-Alpes-Côte d'Azur Region, France
CHU Pellegrin
Bordeaux, France
Hospices Civils de Lyon
Lyon, France
Hopital Armand Trousseau
Paris, France
Hopital Necker
Paris, France